Ironwood Pharmaceuticals IRWD Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $220.47M+2.3% | $215.46M+53.5% | $140.41M+51.2% | $92.85M-14.4% | $108.48M+22.5% | ||
| $105.84M+126% | $46.75M-61.2% | $120.37M+39.7% | $86.17M+117% | $39.77M-51.4% | ||
| $332.29M+21.2% | $274.18M+0.1% | $273.84M+42.8% | $191.75M+19.4% | $160.58M-11.9% | ||
| $3.17M-7.1% | $3.41M-7.0% | $3.67M-6.7% | $3.93M-7.7% | $4.26M-5.3% | ||
| $1.84M-9.9% | $2.04M-9.2% | $2.25M-8.4% | $2.45M-7.7% | $2.66M-7.1% | ||
| $434.57M+9.5% | $396.9M+0.2% | $396.06M+15.5% | $342.95M+4.8% | $327.21M-6.8% | ||
| $3.24M+11.7% | $2.9M+79.7% | $1.61M+16.1% | $1.39M-76.2% | $5.83M+174% | ||
| $199.86M— | —— | —— | —— | —— | ||
| $236.31M-2.4% | $242.22M-0.1% | $242.5M+4.3% | $232.53M+383% | $48.1M+23.8% | ||
| $165K+1.2% | $163K0.0% | $163K+0.6% | $162K0.0% | $162K+1.3% | ||
| -$1.63B+2.4% | -$1.67B-0.1% | -$1.67B+2.3% | -$1.71B+1.4% | -$1.74B-2.2% | ||
| -$217.14M+17.1% | -$261.84M+0.9% | -$264.16M+14.3% | -$308.16M+7.8% | -$334.05M-10.9% | ||
| $434.57M+9.5% | $396.9M+0.2% | $396.06M+15.5% | $342.95M+4.8% | $327.21M-6.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Ironwood Pharmaceuticals's total assets?
- Ironwood Pharmaceuticals (IRWD) holds $434.6M in total assets, up 32.8% year over year.
- How much debt does Ironwood Pharmaceuticals have?
- Ironwood Pharmaceuticals carries $212.4M in total debt against -$217.1M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Ironwood Pharmaceuticals have?
- Ironwood Pharmaceuticals holds $220.5M in cash and equivalents.
- Can Ironwood Pharmaceuticals cover its short-term obligations?
- Its current ratio is 1.41 — current assets exceed current liabilities.
- Where does Ironwood Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
